APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABAB Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global GABAB Receptor Agonists Market Analysis and Forecast 2026-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchGABAB Receptor Agonists Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal GABAB Receptor Agonists Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal GABAB Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABAB Receptor Agonists Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal GABAB Receptor Agonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global GABAB Receptor Agonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for GABAB Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for GABAB Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for GABAB Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for GABAB Receptor Agonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of GABAB Receptor Agonists include Xi'an Libang Pharmaceuticals, Xi'an Hanfeng Pharmaceuticals, Sun Pharma, Hemony Pharmaceutical, Sichuan Ren'an Pharmaceuticals, Novartis, Nanjing Haina Pharmaceutical, China Resources Double Crane Pharmaceuticals and Fuan Pharmaceutical Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for GABAB Receptor Agonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of GABAB Receptor Agonists, also provides the sales of main regions and countries. Of the upcoming market potential for GABAB Receptor Agonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the GABAB Receptor Agonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global GABAB Receptor Agonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for GABAB Receptor Agonists sales, projected growth trends, production technology, application and end-user industry.

GABAB Receptor Agonists Segment by Company

Xi'an Libang Pharmaceuticals

Xi'an Hanfeng Pharmaceuticals

Sun Pharma

Hemony Pharmaceutical

Sichuan Ren'an Pharmaceuticals

Novartis

Nanjing Haina Pharmaceutical

China Resources Double Crane Pharmaceuticals

Fuan Pharmaceutical Group

Chengdu Beite

Viatris

Jazz Pharmaceuicals

Hikma

GABAB Receptor Agonists Segment by Type

Baclofen

γ-hydroxybutyrate(GHB)）

GABAB Receptor Agonists Segment by Application

Hospital

Clinic

Other

GABAB Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABAB Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABAB Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABAB Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of GABAB Receptor Agonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of GABAB Receptor Agonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GABAB Receptor Agonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GABAB Receptor Agonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Baclofen Major Manufacturers Table 3. γ-hydroxybutyrate(GHB)） Major Manufacturers Table 4. Global GABAB Receptor Agonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. GABAB Receptor Agonists Industry Trends Table 9. GABAB Receptor Agonists Industry Drivers Table 10. GABAB Receptor Agonists Industry Opportunities and Challenges Table 11. GABAB Receptor Agonists Industry Restraints Table 12. Global GABAB Receptor Agonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global GABAB Receptor Agonists Revenue by Region (2021-2026) & (US$ Million) Table 14. Global GABAB Receptor Agonists Revenue by Region (2027-2032) & (US$ Million) Table 15. Global GABAB Receptor Agonists Revenue Market Share by Region (2021-2026) Table 16. Global GABAB Receptor Agonists Revenue Market Share by Region (2027-2032) Table 17. Global GABAB Receptor Agonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global GABAB Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 19. Global GABAB Receptor Agonists Sales by Region (2027-2032) & (K Units) Table 20. Global GABAB Receptor Agonists Sales Market Share by Region (2021-2026) Table 21. Global GABAB Receptor Agonists Sales Market Share by Region (2027-2032) Table 22. Global GABAB Receptor Agonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global GABAB Receptor Agonists Revenue Market Share by Manufacturers (2021-2026) Table 24. Global GABAB Receptor Agonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global GABAB Receptor Agonists Sales Market Share by Manufacturers (2021-2026) Table 26. Global GABAB Receptor Agonists Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global GABAB Receptor Agonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global GABAB Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global GABAB Receptor Agonists Manufacturers, Product Type & Application Table 30. Global GABAB Receptor Agonists Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global GABAB Receptor Agonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global GABAB Receptor Agonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global GABAB Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 35. Global GABAB Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 36. Global GABAB Receptor Agonists Revenue Market Share by Type (2021-2026) Table 37. Global GABAB Receptor Agonists Revenue Market Share by Type (2027-2032) Table 38. Global GABAB Receptor Agonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 40. Global GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 41. Global GABAB Receptor Agonists Sales Market Share by Type (2021-2026) Table 42. Global GABAB Receptor Agonists Sales Market Share by Type (2027-2032) Table 43. Global GABAB Receptor Agonists Price by Type (2021-2026) & (US$/Unit) Table 44. Global GABAB Receptor Agonists Price by Type (2027-2032) & (US$/Unit) Table 45. Global GABAB Receptor Agonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global GABAB Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 47. Global GABAB Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 48. Global GABAB Receptor Agonists Revenue Market Share by Application (2021-2026) Table 49. Global GABAB Receptor Agonists Revenue Market Share by Application (2027-2032) Table 50. Global GABAB Receptor Agonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 52. Global GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 53. Global GABAB Receptor Agonists Sales Market Share by Application (2021-2026) Table 54. Global GABAB Receptor Agonists Sales Market Share by Application (2027-2032) Table 55. Global GABAB Receptor Agonists Price by Application (2021-2026) & (US$/Unit) Table 56. Global GABAB Receptor Agonists Price by Application (2027-2032) & (US$/Unit) Table 57. Xi'an Libang Pharmaceuticals Company Information Table 58. Xi'an Libang Pharmaceuticals Business Overview Table 59. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 61. Xi'an Libang Pharmaceuticals Recent Development Table 62. Xi'an Hanfeng Pharmaceuticals Company Information Table 63. Xi'an Hanfeng Pharmaceuticals Business Overview Table 64. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 66. Xi'an Hanfeng Pharmaceuticals Recent Development Table 67. Sun Pharma Company Information Table 68. Sun Pharma Business Overview Table 69. Sun Pharma GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sun Pharma GABAB Receptor Agonists Product Portfolio Table 71. Sun Pharma Recent Development Table 72. Hemony Pharmaceutical Company Information Table 73. Hemony Pharmaceutical Business Overview Table 74. Hemony Pharmaceutical GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio Table 76. Hemony Pharmaceutical Recent Development Table 77. Sichuan Ren'an Pharmaceuticals Company Information Table 78. Sichuan Ren'an Pharmaceuticals Business Overview Table 79. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 81. Sichuan Ren'an Pharmaceuticals Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novartis GABAB Receptor Agonists Product Portfolio Table 86. Novartis Recent Development Table 87. Nanjing Haina Pharmaceutical Company Information Table 88. Nanjing Haina Pharmaceutical Business Overview Table 89. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio Table 91. Nanjing Haina Pharmaceutical Recent Development Table 92. China Resources Double Crane Pharmaceuticals Company Information Table 93. China Resources Double Crane Pharmaceuticals Business Overview Table 94. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio Table 96. China Resources Double Crane Pharmaceuticals Recent Development Table 97. Fuan Pharmaceutical Group Company Information Table 98. Fuan Pharmaceutical Group Business Overview Table 99. Fuan Pharmaceutical Group GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio Table 101. Fuan Pharmaceutical Group Recent Development Table 102. Chengdu Beite Company Information Table 103. Chengdu Beite Business Overview Table 104. Chengdu Beite GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Chengdu Beite GABAB Receptor Agonists Product Portfolio Table 106. Chengdu Beite Recent Development Table 107. Viatris Company Information Table 108. Viatris Business Overview Table 109. Viatris GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Viatris GABAB Receptor Agonists Product Portfolio Table 111. Viatris Recent Development Table 112. Jazz Pharmaceuicals Company Information Table 113. Jazz Pharmaceuicals Business Overview Table 114. Jazz Pharmaceuicals GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio Table 116. Jazz Pharmaceuicals Recent Development Table 117. Hikma Company Information Table 118. Hikma Business Overview Table 119. Hikma GABAB Receptor Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hikma GABAB Receptor Agonists Product Portfolio Table 121. Hikma Recent Development Table 122. North America GABAB Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 123. North America GABAB Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 124. North America GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 125. North America GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 126. North America GABAB Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America GABAB Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America GABAB Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 129. North America GABAB Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 130. North America GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 131. North America GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 132. North America GABAB Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America GABAB Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America GABAB Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America GABAB Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. North America GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 139. North America GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 140. North America GABAB Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America GABAB Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 143. Canada GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 144. Europe GABAB Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe GABAB Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 147. Europe GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 148. Europe GABAB Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 149. Europe GABAB Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 150. Europe GABAB Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 151. Europe GABAB Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 152. Europe GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 153. Europe GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 154. Europe GABAB Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 155. Europe GABAB Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Europe GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe GABAB Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. Europe GABAB Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. Europe GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 160. Europe GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 161. Europe GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 162. Europe GABAB Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 163. Europe GABAB Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 164. Germany GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 165. France GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 166. U.K. GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 167. Italy GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 168. Netherlands GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 169. China GABAB Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 170. China GABAB Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 171. China GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 172. China GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 173. China GABAB Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 174. China GABAB Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 175. China GABAB Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 176. China GABAB Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 177. China GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 178. China GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 179. China GABAB Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 180. China GABAB Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Asia GABAB Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia GABAB Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 184. Asia GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 185. Asia GABAB Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 186. Asia GABAB Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 187. Asia GABAB Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia GABAB Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 190. Asia GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 191. Asia GABAB Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 192. Asia GABAB Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 193. Asia GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia GABAB Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia GABAB Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 197. Asia GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 198. Asia GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 199. Asia GABAB Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 200. Asia GABAB Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 201. Japan GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 202. South Korea GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 203. India GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 204. Australia GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 205. China Taiwan GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 207. SAMEA GABAB Receptor Agonists Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA GABAB Receptor Agonists Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA GABAB Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 210. SAMEA GABAB Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 211. SAMEA GABAB Receptor Agonists Sales Price by Type (2021-2026) & (US$/Unit) Table 212. SAMEA GABAB Receptor Agonists Sales Price by Type (2027-2032) & (US$/Unit) Table 213. SAMEA GABAB Receptor Agonists Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA GABAB Receptor Agonists Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA GABAB Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 216. SAMEA GABAB Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 217. SAMEA GABAB Receptor Agonists Sales Price by Application (2021-2026) & (US$/Unit) Table 218. SAMEA GABAB Receptor Agonists Sales Price by Application (2027-2032) & (US$/Unit) Table 219. SAMEA GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA GABAB Receptor Agonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA GABAB Receptor Agonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 223. SAMEA GABAB Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 224. SAMEA GABAB Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 225. SAMEA GABAB Receptor Agonists Sales Price by Country (2021-2026) & (US$/Unit) Table 226. SAMEA GABAB Receptor Agonists Sales Price by Country (2027-2032) & (US$/Unit) Table 227. Brazil GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 228. Argentina GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 229. Chile GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 230. Colombia GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 231. Peru GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 233. Israel GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 234. UAE GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 235. Turkey GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 236. Iran GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 237. Egypt GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. GABAB Receptor Agonists Distributors List Table 241. GABAB Receptor Agonists Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. GABAB Receptor Agonists Image Figure 2. Global GABAB Receptor Agonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABAB Receptor Agonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. Baclofen Image Figure 5. γ-hydroxybutyrate(GHB)） Image Figure 6. Global GABAB Receptor Agonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global GABAB Receptor Agonists Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global GABAB Receptor Agonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global GABAB Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 13. Global GABAB Receptor Agonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global GABAB Receptor Agonists Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global GABAB Receptor Agonists Revenue Market Share by Region (2021-2032) Figure 16. Global GABAB Receptor Agonists Sales (2021-2032) & (K Units) Figure 17. Global GABAB Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global GABAB Receptor Agonists Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico GABAB Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 20. Europe GABAB Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 21. China GABAB Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) GABAB Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa GABAB Receptor Agonists Sales YoY (2021-2032) & (K Units) Figure 24. Global GABAB Receptor Agonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global GABAB Receptor Agonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global GABAB Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global GABAB Receptor Agonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global GABAB Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 30. Global GABAB Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global GABAB Receptor Agonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global GABAB Receptor Agonists Sales Market Share by Type (2021-2032) Figure 33. Global GABAB Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global GABAB Receptor Agonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global GABAB Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 36. Global GABAB Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global GABAB Receptor Agonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global GABAB Receptor Agonists Sales Market Share by Application (2021-2032) Figure 39. North America GABAB Receptor Agonists Revenue Share by Type (2021-2032) Figure 40. North America GABAB Receptor Agonists Sales Share by Type (2021-2032) Figure 41. North America GABAB Receptor Agonists Revenue Share by Application (2021-2032) Figure 42. North America GABAB Receptor Agonists Sales Share by Application (2021-2032) Figure 43. North America GABAB Receptor Agonists Revenue Share by Country (2021-2032) Figure 44. North America GABAB Receptor Agonists Sales Share by Country (2021-2032) Figure 45. Europe GABAB Receptor Agonists Revenue Share by Type (2021-2032) Figure 46. Europe GABAB Receptor Agonists Sales Share by Type (2021-2032) Figure 47. Europe GABAB Receptor Agonists Revenue Share by Application (2021-2032) Figure 48. Europe GABAB Receptor Agonists Sales Share by Application (2021-2032) Figure 49. Europe GABAB Receptor Agonists Revenue Share by Country (2021-2032) Figure 50. Europe GABAB Receptor Agonists Sales Share by Country (2021-2032) Figure 51. China GABAB Receptor Agonists Revenue Share by Type (2021-2032) Figure 52. China GABAB Receptor Agonists Sales Share by Type (2021-2032) Figure 53. China GABAB Receptor Agonists Revenue Share by Application (2021-2032) Figure 54. China GABAB Receptor Agonists Sales Share by Application (2021-2032) Figure 55. Asia GABAB Receptor Agonists Revenue Share by Type (2021-2032) Figure 56. Asia GABAB Receptor Agonists Sales Share by Type (2021-2032) Figure 57. Asia GABAB Receptor Agonists Revenue Share by Application (2021-2032) Figure 58. Asia GABAB Receptor Agonists Sales Share by Application (2021-2032) Figure 59. Asia GABAB Receptor Agonists Revenue Share by Country (2021-2032) Figure 60. Asia GABAB Receptor Agonists Sales Share by Country (2021-2032) Figure 61. SAMEA GABAB Receptor Agonists Revenue Share by Type (2021-2032) Figure 62. SAMEA GABAB Receptor Agonists Sales Share by Type (2021-2032) Figure 63. SAMEA GABAB Receptor Agonists Revenue Share by Application (2021-2032) Figure 64. SAMEA GABAB Receptor Agonists Sales Share by Application (2021-2032) Figure 65. SAMEA GABAB Receptor Agonists Revenue Share by Country (2021-2032) Figure 66. SAMEA GABAB Receptor Agonists Sales Share by Country (2021-2032) Figure 67. GABAB Receptor Agonists Value Chain Figure 68. Manufacturing Cost Structure Figure 69. GABAB Receptor Agonists Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Baclofen
  • γ-hydroxybutyrate(GHB)）
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Xi'an Libang Pharmaceuticals
  • Xi'an Hanfeng Pharmaceuticals
  • Sun Pharma
  • Hemony Pharmaceutical
  • Sichuan Ren'an Pharmaceuticals
  • Novartis
  • Nanjing Haina Pharmaceutical
  • China Resources Double Crane Pharmaceuticals
  • Fuan Pharmaceutical Group
  • Chengdu Beite
  • Viatris
  • Jazz Pharmaceuicals
  • Hikma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 GABAB Receptor Agonists Market by Type
  3. 1.2.1 Global GABAB Receptor Agonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Baclofen
  5. 1.2.3 γ-hydroxybutyrate(GHB)）
  6. 1.3 GABAB Receptor Agonists Market by Application
  7. 1.3.1 Global GABAB Receptor Agonists Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 GABAB Receptor Agonists Market Dynamics
  1. 2.1 GABAB Receptor Agonists Industry Trends
  2. 2.2 GABAB Receptor Agonists Industry Drivers
  3. 2.3 GABAB Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 GABAB Receptor Agonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global GABAB Receptor Agonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global GABAB Receptor Agonists Revenue by Region
  3. 3.2.1 Global GABAB Receptor Agonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global GABAB Receptor Agonists Revenue by Region (2021-2026)
  5. 3.2.3 Global GABAB Receptor Agonists Revenue by Region (2027-2032)
  6. 3.2.4 Global GABAB Receptor Agonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global GABAB Receptor Agonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global GABAB Receptor Agonists Sales by Region
  9. 3.4.1 Global GABAB Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global GABAB Receptor Agonists Sales by Region (2021-2026)
  11. 3.4.3 Global GABAB Receptor Agonists Sales by Region (2027-2032)
  12. 3.4.4 Global GABAB Receptor Agonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global GABAB Receptor Agonists Revenue by Manufacturers
  2. 4.1.1 Global GABAB Receptor Agonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global GABAB Receptor Agonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global GABAB Receptor Agonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global GABAB Receptor Agonists Sales by Manufacturers
  6. 4.2.1 Global GABAB Receptor Agonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global GABAB Receptor Agonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global GABAB Receptor Agonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global GABAB Receptor Agonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global GABAB Receptor Agonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global GABAB Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global GABAB Receptor Agonists Manufacturers, Product Type & Application
  13. 4.7 Global GABAB Receptor Agonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global GABAB Receptor Agonists Market CR5 and HHI
  16. 4.8.2 2025 GABAB Receptor Agonists Tier 1, Tier 2, and Tier 3
5 GABAB Receptor Agonists Market by Type
  1. 5.1 Global GABAB Receptor Agonists Revenue by Type
  2. 5.1.1 Global GABAB Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global GABAB Receptor Agonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global GABAB Receptor Agonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global GABAB Receptor Agonists Sales by Type
  6. 5.2.1 Global GABAB Receptor Agonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GABAB Receptor Agonists Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global GABAB Receptor Agonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global GABAB Receptor Agonists Price by Type
6 GABAB Receptor Agonists Market by Application
  1. 6.1 Global GABAB Receptor Agonists Revenue by Application
  2. 6.1.1 Global GABAB Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global GABAB Receptor Agonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global GABAB Receptor Agonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global GABAB Receptor Agonists Sales by Application
  6. 6.2.1 Global GABAB Receptor Agonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global GABAB Receptor Agonists Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global GABAB Receptor Agonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global GABAB Receptor Agonists Price by Application
7 Company Profiles
  1. 7.1 Xi'an Libang Pharmaceuticals
  2. 7.1.1 Xi'an Libang Pharmaceuticals Company Information
  3. 7.1.2 Xi'an Libang Pharmaceuticals Business Overview
  4. 7.1.3 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Xi'an Libang Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  6. 7.1.5 Xi'an Libang Pharmaceuticals Recent Developments
  7. 7.2 Xi'an Hanfeng Pharmaceuticals
  8. 7.2.1 Xi'an Hanfeng Pharmaceuticals Company Information
  9. 7.2.2 Xi'an Hanfeng Pharmaceuticals Business Overview
  10. 7.2.3 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Xi'an Hanfeng Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  12. 7.2.5 Xi'an Hanfeng Pharmaceuticals Recent Developments
  13. 7.3 Sun Pharma
  14. 7.3.1 Sun Pharma Company Information
  15. 7.3.2 Sun Pharma Business Overview
  16. 7.3.3 Sun Pharma GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sun Pharma GABAB Receptor Agonists Product Portfolio
  18. 7.3.5 Sun Pharma Recent Developments
  19. 7.4 Hemony Pharmaceutical
  20. 7.4.1 Hemony Pharmaceutical Company Information
  21. 7.4.2 Hemony Pharmaceutical Business Overview
  22. 7.4.3 Hemony Pharmaceutical GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hemony Pharmaceutical GABAB Receptor Agonists Product Portfolio
  24. 7.4.5 Hemony Pharmaceutical Recent Developments
  25. 7.5 Sichuan Ren'an Pharmaceuticals
  26. 7.5.1 Sichuan Ren'an Pharmaceuticals Company Information
  27. 7.5.2 Sichuan Ren'an Pharmaceuticals Business Overview
  28. 7.5.3 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sichuan Ren'an Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  30. 7.5.5 Sichuan Ren'an Pharmaceuticals Recent Developments
  31. 7.6 Novartis
  32. 7.6.1 Novartis Company Information
  33. 7.6.2 Novartis Business Overview
  34. 7.6.3 Novartis GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Novartis GABAB Receptor Agonists Product Portfolio
  36. 7.6.5 Novartis Recent Developments
  37. 7.7 Nanjing Haina Pharmaceutical
  38. 7.7.1 Nanjing Haina Pharmaceutical Company Information
  39. 7.7.2 Nanjing Haina Pharmaceutical Business Overview
  40. 7.7.3 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nanjing Haina Pharmaceutical GABAB Receptor Agonists Product Portfolio
  42. 7.7.5 Nanjing Haina Pharmaceutical Recent Developments
  43. 7.8 China Resources Double Crane Pharmaceuticals
  44. 7.8.1 China Resources Double Crane Pharmaceuticals Company Information
  45. 7.8.2 China Resources Double Crane Pharmaceuticals Business Overview
  46. 7.8.3 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 China Resources Double Crane Pharmaceuticals GABAB Receptor Agonists Product Portfolio
  48. 7.8.5 China Resources Double Crane Pharmaceuticals Recent Developments
  49. 7.9 Fuan Pharmaceutical Group
  50. 7.9.1 Fuan Pharmaceutical Group Company Information
  51. 7.9.2 Fuan Pharmaceutical Group Business Overview
  52. 7.9.3 Fuan Pharmaceutical Group GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Fuan Pharmaceutical Group GABAB Receptor Agonists Product Portfolio
  54. 7.9.5 Fuan Pharmaceutical Group Recent Developments
  55. 7.10 Chengdu Beite
  56. 7.10.1 Chengdu Beite Company Information
  57. 7.10.2 Chengdu Beite Business Overview
  58. 7.10.3 Chengdu Beite GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chengdu Beite GABAB Receptor Agonists Product Portfolio
  60. 7.10.5 Chengdu Beite Recent Developments
  61. 7.11 Viatris
  62. 7.11.1 Viatris Company Information
  63. 7.11.2 Viatris Business Overview
  64. 7.11.3 Viatris GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Viatris GABAB Receptor Agonists Product Portfolio
  66. 7.11.5 Viatris Recent Developments
  67. 7.12 Jazz Pharmaceuicals
  68. 7.12.1 Jazz Pharmaceuicals Company Information
  69. 7.12.2 Jazz Pharmaceuicals Business Overview
  70. 7.12.3 Jazz Pharmaceuicals GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jazz Pharmaceuicals GABAB Receptor Agonists Product Portfolio
  72. 7.12.5 Jazz Pharmaceuicals Recent Developments
  73. 7.13 Hikma
  74. 7.13.1 Hikma Company Information
  75. 7.13.2 Hikma Business Overview
  76. 7.13.3 Hikma GABAB Receptor Agonists Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hikma GABAB Receptor Agonists Product Portfolio
  78. 7.13.5 Hikma Recent Developments
8 North America
  1. 8.1 North America GABAB Receptor Agonists Market Size by Type
  2. 8.1.1 North America GABAB Receptor Agonists Revenue by Type (2021-2032)
  3. 8.1.2 North America GABAB Receptor Agonists Sales by Type (2021-2032)
  4. 8.1.3 North America GABAB Receptor Agonists Price by Type (2021-2032)
  5. 8.2 North America GABAB Receptor Agonists Market Size by Application
  6. 8.2.1 North America GABAB Receptor Agonists Revenue by Application (2021-2032)
  7. 8.2.2 North America GABAB Receptor Agonists Sales by Application (2021-2032)
  8. 8.2.3 North America GABAB Receptor Agonists Price by Application (2021-2032)
  9. 8.3 North America GABAB Receptor Agonists Market Size by Country
  10. 8.3.1 North America GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America GABAB Receptor Agonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe GABAB Receptor Agonists Market Size by Type
  2. 9.1.1 Europe GABAB Receptor Agonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe GABAB Receptor Agonists Sales by Type (2021-2032)
  4. 9.1.3 Europe GABAB Receptor Agonists Price by Type (2021-2032)
  5. 9.2 Europe GABAB Receptor Agonists Market Size by Application
  6. 9.2.1 Europe GABAB Receptor Agonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe GABAB Receptor Agonists Sales by Application (2021-2032)
  8. 9.2.3 Europe GABAB Receptor Agonists Price by Application (2021-2032)
  9. 9.3 Europe GABAB Receptor Agonists Market Size by Country
  10. 9.3.1 Europe GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe GABAB Receptor Agonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China GABAB Receptor Agonists Market Size by Type
  2. 10.1.1 China GABAB Receptor Agonists Revenue by Type (2021-2032)
  3. 10.1.2 China GABAB Receptor Agonists Sales by Type (2021-2032)
  4. 10.1.3 China GABAB Receptor Agonists Price by Type (2021-2032)
  5. 10.2 China GABAB Receptor Agonists Market Size by Application
  6. 10.2.1 China GABAB Receptor Agonists Revenue by Application (2021-2032)
  7. 10.2.2 China GABAB Receptor Agonists Sales by Application (2021-2032)
  8. 10.2.3 China GABAB Receptor Agonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia GABAB Receptor Agonists Market Size by Type
  2. 11.1.1 Asia GABAB Receptor Agonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia GABAB Receptor Agonists Sales by Type (2021-2032)
  4. 11.1.3 Asia GABAB Receptor Agonists Price by Type (2021-2032)
  5. 11.2 Asia GABAB Receptor Agonists Market Size by Application
  6. 11.2.1 Asia GABAB Receptor Agonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia GABAB Receptor Agonists Sales by Application (2021-2032)
  8. 11.2.3 Asia GABAB Receptor Agonists Price by Application (2021-2032)
  9. 11.3 Asia GABAB Receptor Agonists Market Size by Country
  10. 11.3.1 Asia GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia GABAB Receptor Agonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA GABAB Receptor Agonists Market Size by Type
  2. 12.1.1 SAMEA GABAB Receptor Agonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA GABAB Receptor Agonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA GABAB Receptor Agonists Price by Type (2021-2032)
  5. 12.2 SAMEA GABAB Receptor Agonists Market Size by Application
  6. 12.2.1 SAMEA GABAB Receptor Agonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA GABAB Receptor Agonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA GABAB Receptor Agonists Price by Application (2021-2032)
  9. 12.3 SAMEA GABAB Receptor Agonists Market Size by Country
  10. 12.3.1 SAMEA GABAB Receptor Agonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA GABAB Receptor Agonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA GABAB Receptor Agonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 GABAB Receptor Agonists Value Chain Analysis
  2. 13.1.1 GABAB Receptor Agonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 GABAB Receptor Agonists Production Mode & Process
  6. 13.2 GABAB Receptor Agonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 GABAB Receptor Agonists Distributors
  9. 13.2.3 GABAB Receptor Agonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst